Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Lithium Americas Corp — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while Lithium Americas Corp trades at $3.57 (market cap $1.27B). The key difference: Acadia Healthcare Company Inc is far larger — about 2.3× Lithium Americas Corp's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| ACHC | LAC | |
|---|---|---|
Market Cap | $2.94B | $1.27B |
Sector | Health | Basic Materials |
52-Week High | $31.92 | $10.05 |
52-Week Low | $11.68 | $2.55 |
Enterprise Value | $5.45B | $1.39B |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Lithium Americas (LAC) trades at $3.82, up 1.6% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -11.35% and net income of -$122.09M for 2025, though cash flow from financing surged to $1.14B. Construction milestones at Thacker Pass dominate recent news, with analyst consensus leaning toward Hold (53.33%) versus Buy (46.67%) and a $6.25 price target suggesting 64% upside potential.
Outlook remains speculative with high execution risk on Thacker Pass development requiring $1.3-1.6B in 2026 capex. Government support and lithium demand underpin long-term opportunity, but near-term dilution risk from ATM share issuances and negative cash flow from operations (-$61.22M) pressure equity valuation. Investors face binary outcome: project success drives multi-bag returns, while delays or cost overruns could erode shareholder value further.
Trailing returns across standard periods
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →